Series B funding round for Evommune raising $50M in April 2023
Series B funding round for Evommune raising $50M in April 2023
| Investor | Firm Type | Partner |
|---|
Arix BioscienceLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$273.5M
Top Valuation
-
Evommune raised $50M in a Series B round.
The round was announced on 04/01/23.
The round was led by Arix Bioscience.